SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-017250
Filing Date
2023-05-03
Accepted
2023-05-03 16:32:35
Documents
73
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-20230331.htm   iXBRL 10-Q 2260999
2 EX-31.1 adpt-ex31_1.htm EX-31 22780
3 EX-31.2 adpt-ex31_2.htm EX-31 22779
4 EX-32.1 adpt-ex32_1.htm EX-32 14051
5 EX-32.2 adpt-ex32_2.htm EX-32 15839
  Complete submission text file 0000950170-23-017250.txt   8487633

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adpt-20230331_lab.xml EX-101.LAB 424652
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adpt-20230331.xsd EX-101.SCH 54744
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adpt-20230331_pre.xml EX-101.PRE 333741
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adpt-20230331_cal.xml EX-101.CAL 44087
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adpt-20230331_def.xml EX-101.DEF 183044
67 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20230331_htm.xml XML 1640484
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 23884625
SIC: 2836 Biological Products, (No Diagnostic Substances)